CREO MEDICAL GROUP PLC (CREO) — Interim Results

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the CREO MEDICAL GROUP PLC investor presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and can be submitted at any time by the Q and A tab situated in the right corner of your screen. Just simply type in your questions and press send. The company may not be in a position to answer every question it receives during the meeting itself. However, the company will review all questions submitted today and publish responses where it's appropriate to do so. Before we begin, I'd like to submit the following poll. And I'd now like to hand you over to Craig Guilford, CEO. Good afternoon, sir. Good morning. Good afternoon, everybody. I'm Craig, Craig Gulliver, CEO and essentially cofounder of CREO MEDICAL alongside Chris Hancock, who's long time friend and postgraduate. A colleague of mine, Chris started out life working at Gyrus Medical post his post doctorate with from university. Gyrus Medical pioneered the development of laparoscopic surgical instruments based in South Wales. That company was subsequently acquired by Olympus for 2 or $3,000,000,000 back in 2008, 02/2007. And that's the DNA that basically brought us to the world of bringing advanced energy to the field of endoscopy. Let's just skip on to the next one. And so this slide articulates really the journey that we see surgery going on and also the thing that we are gonna be enabling with the technology that we've developed in the last nine years, really, since the the foundation of CREO MEDICAL as it came out of its early infancy. Open surgery, as we all know, started out life with scalpel blades, sharp knives, sutures, and staples. If you're on a ship and you got gangrene across The Atlantic in the late eighteen hundred...